Assenagon Asset Management S.A. Assembly Biosciences, Inc. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$1.7 - $20.52 $732,807 - $8.85 Million	-431,063 Reduced 62.94%	253,783 $416,000
Q2 2022 Jul 27, 2022	BUY	$1.35 - $2.29 $863,809 - $1.47 Million	639,859 Added 1422.32%	684,846 $1.44 Million
Q1 2022 Apr 25, 2022	BUY	$1.46 - $2.45 $65,681 - $110,218	44,987 New	44,987 $93,000
Q4 2019 Jan 17, 2020	SELL	$8.36 - $23.81 $445,537 - $1.27 Million	-53,294 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$9.83 - $14.82 $431,802 - $650,998	-43,927 Reduced 45.18%	53,294 $524,000
Q2 2019 Aug 12, 2019	BUY	$12.9 - $20.8 $1.25 Million - $2.02 Million	97,221 New	97,221 $1.31 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.